NEOADJUVANT
Clinical trials for NEOADJUVANT explained in plain language.
Never miss a new study
Get alerted when new NEOADJUVANT trials appear
Sign up with your email to follow new studies for NEOADJUVANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise in shrinking tough ovarian tumors before surgery
Disease control Recruiting nowThis study tests a new drug combination (carboplatin plus mirvetuximab soravtansine) given before surgery to people with advanced ovarian, fallopian tube, or peritoneal cancer that has a specific protein (FRα). The goal is to see if the treatment shrinks tumors enough to improve …
Matched conditions: NEOADJUVANT
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated May 17, 2026 06:29 UTC
-
New drug cocktail before kidney surgery may keep cancer away longer
Disease control Recruiting nowThis study tests whether giving a combination of two drugs (axitinib and a PD-1 antibody) before surgery can help prevent kidney cancer from coming back. About 298 patients with high-risk kidney cancer will either receive the drug combo before surgery or have surgery alone. The g…
Matched conditions: NEOADJUVANT
Phase: PHASE3 • Sponsor: ZHOU FANGJIAN • Aim: Disease control
Last updated May 17, 2026 06:18 UTC
-
New drug combo shows promise for esophageal cancer before surgery
Disease control Recruiting nowThis study is testing whether adding the drug ivonescimab (AK112) to standard chemotherapy before surgery can help shrink tumors in people with advanced esophageal cancer. About 45 adults with resectable, locally advanced esophageal squamous cell carcinoma will receive the combin…
Matched conditions: NEOADJUVANT
Phase: PHASE1, PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated May 06, 2026 16:01 UTC